|
HSPA8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.81949999803422E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57085999999973E-05 |
| Normal-vs-Stage2 |
5.638800E-04 |
| Normal-vs-Stage3 |
1.32279999998097E-06 |
| Normal-vs-Stage4 |
4.17110000000553E-05 |
| Stage1-vs-Stage2 |
7.134200E-01 |
| Stage1-vs-Stage3 |
6.060000E-02 |
| Stage1-vs-Stage4 |
2.138800E-01 |
| Stage2-vs-Stage3 |
3.289800E-01 |
| Stage2-vs-Stage4 |
4.857200E-01 |
| Stage3-vs-Stage4 |
8.819400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85748999999014E-05 |
| Normal-vs-AfricanAmerican |
1.380620E-04 |
| Normal-vs-Asian |
1.717980E-02 |
| Caucasian-vs-AfricanAmerican |
6.671400E-01 |
| Caucasian-vs-Asian |
1.123950E-01 |
| AfricanAmerican-vs-Asian |
1.341620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.61789999958617E-07 |
| Normal-vs-Female |
5.94069999999558E-05 |
| Male-vs-Female |
5.436400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.627200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.60210000002647E-06 |
| Normal-vs-Age(61-80Yrs) |
1.54712000000057E-05 |
| Normal-vs-Age(81-100Yrs) |
2.172300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.816000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.587600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.892800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.484000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.578600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.744200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.220780E-01 |
| Classical-VS-Follicular |
4.681900E-02 |
| Classical-VS-Other |
4.362300E-02 |
| Classical-VS-Normal |
1.177300E-04 |
| Tall-VS-Follicular |
9.661600E-01 |
| Tall-VS-Other |
2.718600E-01 |
| Tall-VS-Normal |
4.00999999999874E-05 |
| Follicular-VS-Other |
3.631000E-01 |
| Follicular-VS-Normal |
2.8654999999489E-06 |
| Other-VS-Normal |
3.157000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82450000000478E-05 |
| Normal-vs-N1 |
1.92520000052987E-07 |
| N0-vs-N1 |
1.933520E-02 |
|
|
